Kantarjian et al53 assessed the efficacy and protection of dasatinib, as when compared with imatinib, for the main-line treatment method of CML-CP. Five hundred and nineteen individuals with recently diagnosed CML-CP were randomly assigned to acquire dasatinib at a dose of a hundred mg after every day (259 clients) or imatinib in a dose of 400 mg o

-methylation, hydroxylation, glycosylation, and dimerization have a significant effect on the bioavailability and bioactivity of flavonoids and consequently on their own probable part in crops as well as their possible health-associated actions. Hence, the biological activity of biflavonoids differs appreciably in the biological action of their mon